This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07829/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07829/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07829/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07829/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07829/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07829
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07829 n14:DB07829
dcterms:title
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE
adms:identifier
n7:12106168 n8:99444300 n9:DB07829 n10:GG5 n13:10744775
n3:IUPAC-Name
n4:271B4331-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4337-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4336-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4333-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4334-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4335-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B432F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B432D-363D-11E5-9242-09173F13E4C5 n4:271B4330-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B432E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B433D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B433E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4338-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4339-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B433B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B433A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B433C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4343-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4345-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4346-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4342-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4341-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4344-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4332-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B433F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4340-363D-11E5-9242-09173F13E4C5